Metagenomi, Inc. Common Stock (MGX)의 가격은 얼마입니까?

Metagenomi, Inc. Common Stock (MGX)의 가격은 $1.21입니다.

Metagenomi, Inc. Common Stock (MGX)의 시가 총액은 무엇입니까?

Metagenomi, Inc. Common Stock (MGX)의 시가 총액은 $45.55M입니다.

Metagenomi, Inc. Common Stock (MGX) 가격 이력

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

연도	성과
2026 (TTM)	-2.20%
2025	-48.40%
2024	0.00%

연도

성과

2026 (TTM)

-2.20%

2025

-48.40%

2024

0.00%

회사	주가	변동률 1년%	국가
Vertex Pharmaceuticals Incorporated VRTX.US	$539.14	35.65%	US
Argenx SE ARGX.US	$1.04K	56.21%	NL
CSL Limited CSL.AX	$119.69	-17.56%	AU
Lonza Group AG LONN.SW	$761.87	8.65%	CH
Moderna, Inc. MRNA.US	$130.43	397.46%	US

회사

주가

변동률 1년%

국가